Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Mol Oncol (2023) 17(1):326
The program helps the 90% of health care employers who historically have not offered weight loss medication expand GLP-1 access to patients
The injection form bypasses intestinal absorption limitations (intrinsic factor dependence), so patients with malabsorption issues may benefit more from injectable B12 than oral supplementation
It also aids in stress reduction, quicker recovery from jet lag, and skin health improvements
What safety measures should be followed when using GLP-1 medications for advanced kidney disease
A Bayesian hierarchical model was fitted using the brms framework, specifying percent weight change as a Gaussian outcome with (i) drug-specific smooth dose effects (splines by drug), (ii) treatment duration included as a covariate to account for variability in follow-up time across trials, and (iii) a study-level random intercept to account for between-trial heterogeneity
US$ 21.92
US$ 29.88
US$ 26.03
